A study aimed at further elucidation of the relationship between hypotensive activity and structure among analogs of the protoveratrines is reported. A series of synthetic protoverine tetraesters, which differ from each other only in the nature of the acid residue affixed at 6 5 , have been prepared and subjected to preliminary phatmacological evaluation. The results indicate that alteration in the structure of the ester affixed at C16 in analogs of the protoveratrines profoundly affects hypotensive potency.wo recent developments have stimulated Tstudies involving the synthesis and pharmacological evaluation of analogs of the protoveratrines. On the chemical side, our elucidation of the complete structures and configurations of protoveratrine A (I) and protoveratrine B (11) (1) and several related hypotensive ester alkaloids (2, 3) made feasible the systematic alteration of the molecules. On the clinical side, recent work has demonstrated significant differences between protoveratrine A and protoveratrine B when the substances are administered orally, particularly with regard to hypotensive-emetic relationships (4-6). Since protoveratrines A and B differ only in the nature of the ester moiety a t C3, it was deemed desirable that new protoverine (111) (7) esters, which differ from the protoveratrines solely in the nature of the acid residues, should he prepared and subjected to pharmacological evaluation.In our previous studies the compounds examined were protoverine derivatives with varying substitution a t positions 3, 4, 6, 7, 14, 15, and 16 (8-10). The results supported the following generalizations (a) esterification a t position 16 with acetate or isobutyrate is accompanied by a profound loss in activity, (b) esterification a t positions 3 and 15 is required for high activity, chain acid may be disadvantageous, (g) oxidation of the alcohol group at position 16 to a ketone group is accompanied hy a loss in activity, (lz) acetonide formation a t positions 14 and 1.5 is accompanied by a profound loss in activity, (i) esterification a t position 3 may he disadvantageous, and ( j ) considerable alteration can be made in the structure of the ester affixed a t 3 without greatly altering hypotensive potency. In view of the aforementioned facts that minor differences in the ester affixed a t 3 significantly affect the hypotensive-emetic ratio of the protoveratrines and that changes in the structure of the ester at C3 do not greatly alter hypotensive potency, it was deemed desirable that additional compounds which differ from each other only in the nature of the ester a t C15 should be prepared and subjected to pharmacological evaluation. The present report details the synthesis and preliminary pharmacological evaluation of three new analogs of the protoveratrines In the new analogs, the isohutyrate residue, previously demonstrated to he an effective suhstitute for the naturally-occurring substituted a-niethylhutyrate residues (S), is affixed a t C3 Treatment of protoverine (111) with acetone and hydrochloric ac...